ヘルスケアとライフサイエンス市場におけるNLP – 2030年までの世界予測

本調査レポートでは、ヘルスケアとライフサイエンス市場におけるNLPを、提供内容（ソフトウェアおよびサービス）、導入形態（クラウドおよびオンプレミス）、NLPの種類（自然言語理解（NLU）および自然言語生成（NLG））、NLP技術（光学式文字認識（OCR）、固有表現抽出（NER）、感情分析、テキスト分類、トピックモデリング、テキスト要約、その他のNLP技術）、用途（患者ケアおよびエンゲージメント、臨床業務および意思決定支援、バイオメディカル研究および医薬品開発、管理および運用管理、ゲノミクスおよび精密医療、医療教育および知識普及、その他の用途）、エンドユーザー（企業（臨床開業医、医療研究者、医療管理者、健康保険および保険支払専門家、製薬およびバイオテクノロジー企業、その他のエンドユーザー）、地域（北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、ラテンアメリカ）に基づいて分類しています。

The NLP in healthcare & life sciences market is expanding rapidly, with a projected market size rising from USD 5.18 billion in 2025 to USD 16.01 billion by 2030, at a CAGR of 25.3% during the forecast period. The substantial increase in unstructured clinical data, including electronic health records, physician notes, and pathology reports, drives the demand for NLP technologies to derive actionable insights. Simultaneously, clinical decision support is gaining importance, with NLP enabling real-time diagnostics and treatment recommendations in precision medicine. However, outdated IT systems can be incompatible with modern NLP tools, posing integration and interoperability challenges. As healthcare systems modernize, NLP is poised to become a cornerstone of data-driven, personalized care delivery.

ヘルスケアとライフサイエンス市場におけるNLPは急速に拡大しており、市場規模は2025年の51億8,000万米ドルから2030年には160億1,000万米ドルに拡大すると予測されています。予測期間中の年平均成長率（CAGR）は25.3%です。電子カルテ、医師の診断書、病理報告書など、非構造化臨床データの大幅な増加により、実用的な洞察を導き出すNLP技術の需要が高まっています。同時に、臨床意思決定支援の重要性が高まっており、NLPは精密医療におけるリアルタイムの診断と治療推奨を可能にします。しかし、時代遅れのITシステムは最新のNLPツールと互換性がない場合があり、統合と相互運用性の課題が生じています。ヘルスケアシステムの近代化に伴い、NLPはデータ主導型の個別化ケア提供の基盤となることが期待されています。

“NLG type segment to account for the fastest growth rate during the forecast period”

Natural language generation (NLG) is the fastest-growing segment in the NLP in healthcare and life sciences market. NLG transforms structured clinical data into clear, human-like narratives, improving clinical documentation and reducing physician workload. It automates the creation of patient summaries, discharge notes, and personalized communications, enhancing patient engagement and adherence to treatment. The rising need for efficient data handling and automation in healthcare drives NLG adoption. As healthcare providers focus on improving operational efficiency and patient outcomes, NLG becomes a critical tool for enabling scalable, accurate, and timely clinical documentation and communication within the NLP in healthcare and life sciences market.

“Named entity recognition (NER) NLP technique segment to hold the largest market share during the forecast period”

Named entity recognition (NER) holds the largest market share in NLP in healthcare and life sciences because it is critical in extracting structured information from unstructured medical texts. NER enhances clinical decision-making, medical coding, and data interoperability by identifying and classifying key entities such as diseases, drugs, procedures, and patient information. Its ability to accurately process large volumes of electronic health records, clinical trial data, and biomedical literature makes it essential for improving diagnostics, treatment planning, and research. As healthcare increasingly relies on data-driven insights, NER’s precision and scalability make it a foundational tool across multiple healthcare applications.

“North America leads with advanced infrastructure and early tech adoption, while Asia Pacific records fastest growth  with digitalization and government AI initiatives”

North America leads the NLP in healthcare and life sciences market due to its advanced healthcare IT infrastructure, strong regulatory support for digital health, and early adoption of electronic health records and AI. The region is home to key industry players and research institutions that actively develop and deploy NLP applications for clinical decision-making, patient monitoring, and administrative automation. Meanwhile, Asia Pacific is the fastest-growing market, driven by rapid digitization of healthcare systems, increasing investments in AI, and growing awareness of personalized medicine. China, India, and Japan prioritize healthcare modernization, with government initiatives encouraging AI integration. The region’s rising healthcare demands and technological advancements make it a hotspot for NLP adoption in the coming years.

Breakdown of Primaries

In-depth interviews were conducted with Chief Executive Officers (CEOs), innovation and technology directors, system integrators, and executives from various key organizations operating in the NLP in healthcare & life sciences market.

             By Company: Tier I – 35%, Tier II – 45%, and Tier III – 20%

             By Designation: C-Level Executives – 35%, D-Level Executives –25%, and others – 40%

             By Region: North America – 40%, Europe – 30%, Asia Pacific – 20%, Middle East & Africa – 5%, and Latin America – 5%

The report includes a study of key players offering NLP in healthcare & life sciences. It profiles major vendors in the NLP in healthcare & life sciences market. The major market players include Microsoft (US), Google (US), IBM (US), AWS (US), IQVIA (US), Oracle (US), Inovalon (US), Dolbey Systems (US), Averbis (Germany), SAS Institute (US), Solventum (US), Press Ganey (US), Ellipsis Health (US), Lexalytics (US), NVIDIA (US), GE Healthcare (US), Clinithink (US), HPE (US), Oncora Medical (US), Flatiron Health (US), Datavant (US), Edifecs (US), John Snow Labs (US), ITRex Group (US), KMS Healthcare (US), Appinventiv (India), Reveal HealthTech (US), Veritis (US), Optum (US), Health Catalyst (US), AMBOSS (Germany), Maruti Techlabs (India), DeepScribe (US), ForeSee Medical (US), Gnani.ai (India), Notable Health (US), Biofourmis (US), Suki AI (US), Wave Health Technologies (US), Corti (Denmark), CloudMex (US), Emtelligent (Canada), Enlitic (US), and Deep 6 AI (US).

Research Coverage

This research report categorizes the NLP in healthcare & life sciences market based on Offering (software and services), Deployment mode (cloud & on-premises), NLP type (natural language understanding (NLU) and natural language generation (NLG)), NLP technique (optical character recognition (OCR), named entity recognition (NER), sentiment analysis, text classification, topic modeling, text summarization, other NLP techniques), Application (patient care & engagement, clinical operations & decision support, biomedical research & drug development, administrative & operations management, genomics & precision medicine, medical education & knowledge dissemination and other applications), End User (enterprise (clinical practitioners, healthcare researchers, healthcare administrators, health insurance & payer professional, pharmaceutical & biotech companies and other end users), and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America).

The scope of the report covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the NLP in healthcare & life sciences market. A detailed analysis of the key industry players was done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements, new product & service launches, and mergers and acquisitions; and recent developments associated with the market. This report also covered the competitive analysis of upcoming startups in the market ecosystem.

Key Benefits of Buying the Report

The report will provide the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall NLP in healthcare & life sciences market and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their business and plan suitable go-to-market strategies. It will also help stakeholders understand the market’s pulse and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (NLP makes EHR data actionable by extracting insights from text and large datasets, enhanced decision-making by analyzing complex, unstructured clinical data and supports predictive analytics to identify trends and reduce risks).), restraints (Legacy IT systems hinder compatibility with modern NLP tools and high deployment costs and need for skilled personnel) ), opportunities (Real-time, personalized clinical decision support from diverse data, AI assistants streamlines patient engagement and documentation and multilingual translation improves global healthcare access)), and challenges (Integration with existing workflows requires major adjustments and lack of standardized frameworks for validating NLP effectiveness)).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the NLP in healthcare & life sciences market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the NLP in healthcare & life sciences market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the NLP in healthcare & life sciences market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Microsoft (US), Google (US), IBM (US), AWS (US), IQVIA (US), Oracle (US), Inovalon (US), Dolbey Systems (US), Averbis (Germany), SAS Institute (US), Solventum (US), Press Ganey (US), Ellipsis Health (US), Lexalytics (US), NVIDIA (US), GE Healthcare (US), Clinithink (US), HPE (US), Oncora Medical (US), Flatiron Health (US), Datavant (US), Edifecs (US), John Snow Labs (US), ITRex Group (US), KMS Healthcare (US), Appinventiv (India), Reveal HealthTech (US), Veritis (US), Optum (US), Health Catalyst (US), AMBOSS (Germany), Maruti Techlabs (India), DeepScribe (US), ForeSee Medical (US), Gnani.ai (India), Notable Health (US), Biofourmis (US), Suki AI (US), Wave Health Technologies (US), Corti (Denmark), CloudMex (US), Emtelligent (Canada), Enlitic (US), and Deep 6 AI (US). The report also helps stakeholders understand the pulse of the NLP in healthcare & life sciences market and provides them with information on key market drivers, restraints, challenges, and opportunities.

Table of Contents

1               INTRODUCTION              37

1.1           STUDY OBJECTIVES       37

1.2           MARKET DEFINITION   37

1.3           MARKET SCOPE                38

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 38

1.3.2        INCLUSIONS AND EXCLUSIONS 39

1.3.3        YEARS CONSIDERED      40

1.4           CURRENCY CONSIDERED            40

1.5           STAKEHOLDERS               41

1.6           SUMMARY OF CHANGES               41

2               RESEARCH METHODOLOGY       43

2.1           RESEARCH DATA              43

2.1.1        SECONDARY DATA          44

2.1.1.1    Key data from secondary sources       44

2.1.2        PRIMARY DATA 45

2.1.2.1    List of primary participants 45

2.1.2.2    Breakdown of primaries      45

2.1.2.3    Key data from primary sources           46

2.1.2.4    Key industry insights           46

2.2           MARKET BREAKUP AND DATA TRIANGULATION                 47

2.3           MARKET SIZE ESTIMATION         48

2.3.1        TOP-DOWN APPROACH                48

2.3.2        BOTTOM-UP APPROACH              48

2.4           MARKET FORECAST       52

2.5           RESEARCH ASSUMPTIONS           53

2.6           RESEARCH LIMITATIONS             54

3               EXECUTIVE SUMMARY  55

4               PREMIUM INSIGHTS       61

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN  NLP IN HEALTHCARE & LIFE SCIENCES MARKET        61

4.2           NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION   61

4.3           NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE AND END USER                 62

4.4           NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION                62

5               MARKET OVERVIEW       63

5.1           INTRODUCTION              63

5.2           MARKET DYNAMICS       64

5.2.1        DRIVERS               64

5.2.1.1    Surging volume of unstructured clinical data  64

5.2.1.2    Rising demand for enhanced care delivery and patient engagement           65

5.2.1.3    Need for predictive analytics to improve significant health concerns 65

5.2.1.4    Increasing focus on enhancing clinical decision support                 66

5.2.2        RESTRAINTS      66

5.2.2.1    Clinical accuracy and reliability concerns         66

5.2.2.2    Issues related to domain-specific language and medical terminology in NLP model development          66

5.2.2.3    Complexity in integrating NLP with established healthcare system    67

5.2.3        OPPORTUNITIES              67

5.2.3.1    Rising adoption of computer-assisted coding to enhance productivity           67

5.2.3.2    Emergence of advanced AI technology for generating valuable insights for healthcare          67

5.2.3.3    Emergence of cognitive computing for medicine applications                 68

5.2.4        CHALLENGES    68

5.2.4.1    Model training data limitations          68

5.2.4.2    High cost of implementation and maintenance of NLP technology              68

5.2.4.3    Explainability and interpretability issues while deploying NLP algorithms              69

5.3           IMPACT OF 2025 US TARIFF—NLP IN HEALTHCARE & LIFE SCIENCES MARKET                69

5.3.1        INTRODUCTION              69

5.3.2        KEY TARIFF RATES          70

5.3.3        PRICE IMPACT ANALYSIS             70

5.3.3.1    Strategic shifts and emerging trends 70

5.3.4        IMPACT ON COUNTRY/REGION                71

5.3.4.1    US           71

5.3.4.1.1 Strategic shifts and key observations 71

5.3.4.2    China      72

5.3.4.2.1 Strategic shifts and key observations 73

5.3.4.3    Europe   73

5.3.4.3.1 Strategic shifts and key observations 74

5.3.4.4    India       74

5.3.4.4.1 Strategic shifts and key observations 75

5.3.5        IMPACT ON END-USE INDUSTRIES          75

5.3.5.1    Clinical practitioners            75

5.3.5.2    Healthcare Researchers       76

5.3.5.3    Pharmaceutical & Biotech companies               76

5.4           EVOLUTION OF NLP IN HEALTHCARE & LIFE SCIENCES MARKET               76

5.5           NLP IN HEALTHCARE & LIFE SCIENCES MARKET: ARCHITECTURE                77

5.6           SUPPLY CHAIN ANALYSIS             78

5.7           ECOSYSTEM ANALYSIS  79

5.7.1        SOFTWARE & SERVICE PROVIDERS BY APPLICATION                 82

5.7.1.1    Patient care & engagement 82

5.7.1.2    Clinical operations & decision support              82

5.7.1.3    Biomedical research & drug development        82

5.7.1.4    Administrative & operations management       82

5.7.1.5    Genomics & precision medicine         82

5.7.1.6    Medical education & knowledge dissemination               82

5.8           INVESTMENT LANDSCAPE AND FUNDING SCENARIO                 83

5.9           CASE STUDY ANALYSIS 84

5.9.1        CASE STUDY 1: CSL BEHRING COLLABORATED WITH IQVIA’S NLP TEAM, LINGUAMATICS, TO CREATE PROOF OF CONCEPT            84

5.9.2        CASE STUDY 2: ATRIUS HEALTH USED LINGUAMATICS I2E TO CREATE QUERIES TO EXTRACT CLINICAL DATA FROM FREE-TEXT FIELDS WITHIN CLINICIAN PROGRESS NOTES AND CLINICAL REPORTS        85

5.9.3        CASE STUDY 3: HUMANA ADOPTED WATSON’S VOICE AGENT TO OFFER ENHANCED SELF-SERVICE CAPABILITIES TO HEALTHCARE PROVIDERS           85

5.9.4        CASE STUDY 4: BIOPHARMACEUTICAL COMPANY DEPLOYED IQVIA’S SOLUTIONS TO CONDUCT HEALTH TECHNOLOGY ASSESSMENT      86

5.9.5        CASE STUDY 5: PHILIPS ADOPTED AMAZON’S ELASTIC COMPUTE CLOUD (AMAZON EC2) TO ATTAIN SECURE, RESIZABLE COMPUTING CAPACITY        87

5.10         TECHNOLOGY ANALYSIS             87

5.10.1      KEY TECHNOLOGIES     88

5.10.1.1  Generative AI        88

5.10.1.2  Natural Language Processing (NLP)                88

5.10.1.3  Machine Learning                 88

5.10.1.4  Computer Vision  88

5.10.2      COMPLIMENTARY TECHNOLOGIES        89

5.10.2.1  Conversational AI 89

5.10.2.2  Emotion AI            89

5.10.2.3  Cloud computing  89

5.10.3      ADJACENT TECHNOLOGIES       90

5.10.3.1  Edge AI  90

5.10.3.2  Blockchain             90

5.10.3.3  AR/VR   90

5.11         REGULATORY LANDSCAPE         91

5.11.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             91

5.11.1.1  North America      95

5.11.1.1.1                US           95

5.11.1.1.2                Canada   96

5.11.1.2  Europe   96

5.11.1.3  Asia Pacific            96

5.11.1.3.1                China      96

5.11.1.3.2                India       96

5.11.1.3.3                Japan      96

5.11.1.3.4                South Korea           96

5.11.1.4  Middle East & Africa            96

5.11.1.4.1                UAE        97

5.11.1.4.2                KSA        97

5.11.1.5  Latin America       97

5.11.1.5.1                Brazil      97

5.11.1.5.2                Mexico   97

5.12         PATENT ANALYSIS          97

5.12.1      METHODOLOGY              97

5.12.2      PATENTS FILED, BY DOCUMENT TYPE  98

5.12.3      INNOVATION AND PATENT APPLICATIONS        98

5.13         PRICING ANALYSIS          101

5.13.1      AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING, 2025                 102

5.13.2      AVERAGE SELLING PRICE, BY APPLICATION, 2025                 103

5.14         KEY CONFERENCES AND EVENTS, 2025–2026        104

5.15         NLP IN HEALTHCARE & LIFE SCIENCES MARKET: BUSINESS MODELS         105

5.15.1      SAAS MODEL     105

5.15.2      CONSULTING SERVICES MODEL               105

5.15.3      REVENUE SHARING MODEL        105

5.15.4      PAY-PER-USE MODEL    105

5.16         PORTER’S FIVE FORCES ANALYSIS           105

5.16.1      THREAT OF NEW ENTRANTS      107

5.16.2      THREAT OF SUBSTITUTES          107

5.16.3      BARGAINING POWER OF SUPPLIERS       107

5.16.4      BARGAINING POWER OF BUYERS             107

5.16.5      INTENSITY OF COMPETITIVE RIVALRY 107

5.17         KEY STAKEHOLDERS AND BUYING CRITERIA     108

5.17.1      KEY STAKEHOLDERS IN BUYING PROCESS           108

5.17.2      BUYING CRITERIA           109

5.18         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            109

6               NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING           111

6.1           INTRODUCTION              112

6.1.1        OFFERING: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            112

6.2           SOFTWARE         113

6.2.1        STANDALONE NLP SOFTWARE 114

6.2.1.1    Deliver precise, customized, and secure NLP solutions 114

6.2.2        INTEGRATED NLP SOFTWARE   115

6.2.2.1    Enhance clinical workflows and insights           115

6.3           SERVICES             116

6.3.1        PROFESSIONAL SERVICES            117

6.3.1.1    Empower healthcare & life sciences with expert service solutions                 117

6.3.1.2    Training & Consulting Services         118

6.3.1.3    System integration & implementation               119

6.3.1.4    Support & maintenance       120

6.3.2        MANAGED SERVICES      121

6.3.2.1    Reliable NLP operations with comprehensive managed healthcare services                121

7               NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY DEPLOYMENT MODE    123

7.1           INTRODUCTION              124

7.1.1        DEPLOYMENT MODE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS      124

7.2           CLOUD 125

7.2.1        LEVERAGE CLOUD-BASED NLP FOR SCALABLE AND COST-EFFECTIVE DATA PROCESSING SOLUTIONS          125

7.3           ON-PREMISES   126

7.3.1        SECURE ON-PREMISES NLP DEPLOYMENT FOR COMPLIANCE AND DATA SOVEREIGNTY IN HEALTHCARE                 126

8               NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE     128

8.1           INTRODUCTION              129

8.1.1        NLP TYPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            129

8.2           NATURAL LANGUAGE UNDERSTANDING             130

8.2.1        HARNESSING CLINICAL INSIGHTS BY UNDERSTANDING COMPLEX MEDICAL LANGUAGE IN HEALTHCARE            130

8.3           NATURAL LANGUAGE GENERATION      131

8.3.1        DRIVING HEALTHCARE EFFICIENCY AND PATIENT ENGAGEMENT THROUGH ADVANCED SOLUTIONS        131

9               NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY NLP TECHNIQUE             133

9.1           INTRODUCTION              134

9.1.1        NLP TECHNIQUE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS      134

9.2           OPTICAL CHARACTER RECOGNITION   135

9.2.1        FOCUS ON ENHANCING DATA PROCESSING INTO DIGITAL CONTENT TO DRIVE ADOPTION IN HEALTHCARE SERVICES             135

9.3           NAMED ENTITY RECOGNITION                 136

9.3.1        GROWING NEED TO ENHANCE DATA ORGANIZATION FOR IMPROVED PATIENT CARE TO PROPEL MARKET    136

9.4           SENTIMENT ANALYSIS  137

9.4.1        NEED FOR IMPROVEMENT IN PATIENT CARE AND COMMUNICATION STRATEGIES TO DRIVE MARKET       137

9.5           TEXT CLASSIFICATION 138

9.5.1        EMPHASIS ON EMPOWERING HEALTHCARE ORGANIZATIONS FOR ADVANCED ANALYSIS TO BOOST DEMAND             138

9.6           TOPIC MODELING          139

9.6.1        NEED FOR UNCOVERING INSIGHTS AND TRENDS FROM TEXTUAL DATA TO DRIVE MARKET        139

9.7           TEXT SUMMARIZATION                140

9.7.1        STREAMLINING MEDICAL INSIGHTS IN HEALTHCARE AND LIFE SCIENCES TO DRIVE MARKET                140

9.8           OTHER NLP TECHNIQUES           141

10            NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION   143

10.1         INTRODUCTION              144

10.1.1      APPLICATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            144

10.2         PATIENT CARE & ENGAGEMENT               146

10.2.1      EMPOWERING PATIENT CARE AND ENGAGEMENT THROUGH ADVANCED NLP IN HEALTHCARE SYSTEMS 146

10.2.2      CONVERSATIONAL AI & VIRTUAL ASSISTANTS  147

10.2.3      REMOTE MONITORING & TELEHEALTH SUPPORT                 147

10.2.4      PATIENT FEEDBACK & SENTIMENT ANALYSIS   148

10.2.5      HEALTH RISK ASSESSMENT        148

10.2.6      OTHERS                148

10.3         CLINICAL OPERATIONS & DECISION SUPPORT 149

10.3.1      UNLOCKING CLINICAL INSIGHTS AND STREAMLINING OPERATIONS WITH NLP FOR ENHANCED DECISION-MAKING AND EFFICIENCY             149

10.3.2      CLINICAL DOCUMENTATION & TRANSCRIPTION                 150

10.3.3      MEDICAL CODING & BILLING AUTOMATION     150

10.3.4      CLINICAL DECISION SUPPORT  151

10.3.5      CLINICAL TRIAL MATCHING      151

10.3.6      OTHERS                151

10.4         BIOMEDICAL RESEARCH & DRUG DEVELOPMENT                 152

10.4.1      ACCELERATING DRUG DISCOVERY AND RESEARCH INSIGHTS USING NLP IN HEALTHCARE 152

10.4.2      LITERATURE MINING & KNOWLEDGE EXTRACTION                 153

10.4.3      DRUG DISCOVERY & REPURPOSING       153

10.4.4      CLINICAL TRIAL DESIGN & OPTIMIZATION         153

10.4.5      PHARMACOVIGILANCE & SAFETY MONITORING                 153

10.4.6      OTHERS                154

10.5         ADMINISTRATIVE & OPERATIONS MANAGEMENT                 154

10.5.1      STREAMLINING ADMINISTRATIVE WORKFLOWS WITH NLP TO BOOST EFFICIENCY AND ACCURACY IN HEALTHCARE OPERATIONS     154

10.5.2      PRIOR AUTHORIZATION & UTILIZATION MANAGEMENT 155

10.5.3      PROVIDER PERFORMANCE & QUALITY REPORTING                 155

10.5.4      INTEROPERABILITY & DATA NORMALIZATION 156

10.5.5      REVENUE CYCLE MANAGEMENT              156

10.5.6      OTHERS                156

10.6         GENOMICS & PRECISION MEDICINE       157

10.6.1      UNLOCKING GENOMIC INSIGHTS WITH NLP TO ENHANCE PRECISION MEDICINE AND PERSONALIZED CARE                 157

10.6.2      GENOMIC REPORT INTERPRETATION   158

10.6.3      INTEGRATING GENOMIC & CLINICAL DATA       158

10.6.4      OTHERS                158

10.7         MEDICAL EDUCATION & KNOWLEDGE DISSEMINATION                 159

10.7.1      ENHANCING MEDICAL EDUCATION AND KNOWLEDGE SHARING WITH NLP FOR PERSONALIZED, EFFICIENT HEALTHCARE LEARNING             159

10.8         OTHER APPLICATIONS 160

11            NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER            162

11.1         INTRODUCTION              163

11.1.1      END USER: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            163

11.2         CLINICAL PRACTITIONERS         164

11.2.1      GROWING NEED TO ENHANCE TREATMENT PLANNING TO SPUR DEMAND          164

11.2.2      PHYSICIANS/DOCTORS 165

11.2.3      NURSES                165

11.2.4      PHARMACISTS  166

11.2.5      OTHERS                166

11.3         HEALTHCARE RESEARCHERS     166

11.3.1      NEED FOR ANALYZING LARGE AMOUNT OF MEDICAL DATA FROM VARIOUS SOURCES TO DRIVE MARKET       166

11.3.2      CLINICAL RESEARCHERS              167

11.3.3      BIOMEDICAL SCIENTISTS            167

11.3.4      EPIDEMIOLOGISTS         168

11.3.5      OTHERS                168

11.4         HEALTHCARE ADMINISTRATORS             168

11.4.1      FOCUS ON ENHANCING OPERATIONAL EFFICIENCY AND DECISION-MAKING TO ENCOURAGE MARKET EXPANSION                 168

11.4.2      HOSPITAL ADMINISTRATORS    169

11.4.3      HEALTH IT MANAGERS 169

11.4.4      HEALTHCARE DATA ANALYST  170

11.4.5      OTHERS                170

11.5         HEALTH INSURANCE & PAYER PROFESSIONALS                 170

11.5.1      USE OF NLP TECHNIQUES TO IMPROVE VARIOUS ASPECTS OF OPERATIONS           170

11.5.2      HEALTH INSURANCE COMPANIES           171

11.5.3      GOVERNMENT HEALTH AGENCIES         171

11.5.4      OTHERS                172

11.6         PHARMACEUTICAL & BIOTECH COMPANIES      172

11.6.1      EMPHASIS ON GAINING INSIGHTS INTO DRUG SAFETY TO DRIVE ADOPTION OF NLP TECHNIQUES      172

11.6.2      MEDICAL AFFAIRS & MARKET RESEARCHERS     173

11.6.3      REGULATORY AFFAIRS 173

11.6.4      PHARMACOVIGILANCE DEPARTMENT  173

11.6.5      OTHERS                174

11.7         OTHER END USERS         174

12            NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION                176

12.1         INTRODUCTION              177

12.2         NORTH AMERICA             179

12.2.1      NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS      179

12.2.2      NORTH AMERICA: MACROECONOMIC OUTLOOK                 180

12.2.3      US           186

12.2.3.1  Driving innovation and efficiency in healthcare and life sciences with NLP                186

12.2.4      CANADA               187

12.2.4.1  Accelerating healthcare innovation and research through NLP technology integration         187

12.3         EUROPE               188

12.3.1      EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            189

12.3.2      EUROPE: MACROECONOMIC OUTLOOK               189

12.3.3      UK          195

12.3.3.1  Advancing national NLP integration in NHS for real-time clinical insights and patient engagement        195

12.3.4      GERMANY           196

12.3.4.1  Driving AI-based diagnostics and ensuring GDPR-compliant NLP solutions in healthcare systems 196

12.3.5      FRANCE                197

12.3.5.1  Accelerating healthcare innovation with government-backed NLP initiatives and multilingual medical applications   197

12.3.6      ITALY    198

12.3.6.1  Transforming clinical data management and enhancing predictive analytics through NLP adoption      198

12.3.7      SPAIN    199

12.3.7.1  Digitally empowering public healthcare and extracting actionable insights from clinical text with NLP  199

12.3.8      REST OF EUROPE             199

12.4         ASIA PACIFIC     201

12.4.1      ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            201

12.4.2      ASIA PACIFIC: MACROECONOMIC OUTLOOK     201

12.4.3      CHINA  208

12.4.3.1  Advancing NLP-driven clinical efficiency and patient care through AI innovation in China         208

12.4.4      JAPAN   209

12.4.4.1  Driving efficient healthcare and personalized care for aging population using advanced NLP technologies 209

12.4.5      INDIA    210

12.4.5.1  Driving NLP adoption by digitizing records, enhancing telehealth, and improving patient engagement in India 210

12.4.6      SOUTH KOREA  211

12.4.6.1  Advancing accurate clinical data analysis and AI diagnostics to transform healthcare            211

12.4.7      AUSTRALIA & NEW ZEALAND     211

12.4.7.1  Enhancing clinical data management and personalized care through advanced NLP adoption       211

12.4.8      ASEAN  212

12.4.8.1  Driving multilingual NLP solutions and digital healthcare transformation to enhance ASEAN patient care access 212

12.4.9      REST OF ASIA PACIFIC   213

12.5         MIDDLE EAST & AFRICA                214

12.5.1      MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS      215

12.5.2      MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK                 215

12.5.3      SAUDI ARABIA  221

12.5.3.1  Streamlining clinical documentation for better patient care outcomes to drive market    221

12.5.4      UAE        222

12.5.4.1  Government Leadership and Collaborative Innovation to boost NLP adoption in healthcare                222

12.5.5      SOUTH AFRICA 223

12.5.5.1  Multilingual demands and digital gaps to drive demand for NLP                 223

12.5.6      ISRAEL  224

12.5.6.1  Startup Innovation and institutional support drive NLP demand in healthcare and life sciences            224

12.5.7      REST OF MIDDLE EAST & AFRICA             225

12.6         LATIN AMERICA                226

12.6.1      LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET DRIVERS            227

12.6.2      LATIN AMERICA: MACROECONOMIC OUTLOOK                 227

12.6.3      BRAZIL 233

12.6.3.1  Advanced NLP adoption with new regulations and partnerships to drive market      233

12.6.4      MEXICO                234

12.6.4.1  Enhancing clinical decision support to boost NLP adoption in healthcare sector  234

12.6.5      ARGENTINA       235

12.6.5.1  Need or deployment of sophisticated algorithms to analyze clinical notes to boost demand           235

12.6.6      REST OF LATIN AMERICA             236

13            COMPETITIVE LANDSCAPE         238

13.1         OVERVIEW          238

13.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025                 238

13.3         REVENUE ANALYSIS, 2020–2024  241

13.4         MARKET SHARE ANALYSIS, 2024                 241

13.5         PRODUCT COMPARATIVE ANALYSIS      244

13.5.1      PRODUCT COMPARATIVE ANALYSIS, BY OFFERING                 244

13.5.1.1  Health Discovery (Averbis)                 244

13.5.1.2  Fusion CDI (Dolbey Systems)           245

13.5.1.3  Clinical Documentation Integrity (Solventum)               245

13.5.1.4  Cloud Healthcare API (Google)         245

13.5.1.5  Inovalon ONE platform (Inovalon)   245

13.5.2      PRODUCT COMPARATIVE ANALYSIS, BY APPLICATION                 246

13.5.2.1  IBM Watsonx Assistant (IBM)           246

13.5.2.2  Microsoft Dragon CoPilot (Microsoft)             246

13.5.2.3  Oracle Clinical Digital Assistant (Oracle)        247

13.5.2.4  IQVIA NLP Risk Adjustment (IQVIA)            247

13.5.2.5  AWS HealthLake (AWS)    247

13.6         COMPANY VALUATION AND FINANCIAL METRICS                 248

13.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 249

13.7.1      STARS   249

13.7.2      EMERGING LEADERS     249

13.7.3      PERVASIVE PLAYERS      249

13.7.4      PARTICIPANTS 249

13.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         251

13.7.5.1  Company footprint               251

13.7.5.2  Regional footprint                 251

13.7.5.3  Offering footprint 252

13.7.5.4  Application footprint            253

13.7.5.5  End user footprint                 254

13.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        255

13.8.1      PROGRESSIVE COMPANIES         255

13.8.2      RESPONSIVE COMPANIES            255

13.8.3      DYNAMIC COMPANIES  255

13.8.4      STARTING BLOCKS         255

13.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 257

13.8.5.1  Detailed list of key startups/SMEs    257

13.8.5.2  Competitive benchmarking of key startups/SMEs          258

13.9         COMPETITIVE SCENARIO AND TRENDS                259

13.9.1      PRODUCT LAUNCHES AND ENHANCEMENTS    259

13.9.2      DEALS  260

14            COMPANY PROFILES      263

14.1         INTRODUCTION              263

14.2         KEY PLAYERS     263

14.2.1      IBM        263

14.2.1.1  Business overview 263

14.2.1.2  Products/Solutions/Services offered 264

14.2.1.3  Recent developments           265

14.2.1.4  MnM view              266

14.2.1.4.1                Right to win           266

14.2.1.4.2                Strategic choices   266

14.2.1.4.3                Weaknesses and competitive threats 266

14.2.2      MICROSOFT       267

14.2.2.1  Business overview 267

14.2.2.2  Products/Solutions/Services offered 268

14.2.2.3  Recent developments           269

14.2.2.4  MnM view              271

14.2.2.4.1                Right to win           271

14.2.2.4.2                Strategic choices   272

14.2.2.4.3                Weaknesses and competitive threats 272

14.2.3      GOOGLE              273

14.2.3.1  Business overview 273

14.2.3.2  Products/Solutions/Services offered 274

14.2.3.3  Recent developments           275

14.2.3.4  MnM view              276

14.2.3.4.1                Right to win           276

14.2.3.4.2                Strategic choices   276

14.2.3.4.3                Weaknesses and competitive threats 277

14.2.4      AWS       278

14.2.4.1  Business overview 278

14.2.4.2  Products/Solutions/Services offered 279

14.2.4.3  Recent developments           279

14.2.4.4  MnM view              282

14.2.4.4.1                Right to win           282

14.2.4.4.2                Strategic choices   282

14.2.4.4.3                Weaknesses and competitive threats 282

14.2.5      IQVIA    283

14.2.5.1  Business overview 283

14.2.5.2  Products/Solutions/Services offered 284

14.2.5.3  Recent developments           285

14.2.5.4  MnM view              287

14.2.5.4.1                Right to win           287

14.2.5.4.2                Strategic choices   287

14.2.5.4.3                Weaknesses and competitive threats 287

14.2.6      ORACLE                288

14.2.6.1  Business overview 288

14.2.6.2  Products/Solutions/Services offered 289

14.2.6.3  Recent developments           290

14.2.7      INOVALON         292

14.2.7.1  Business overview 292

14.2.7.2  Products/Solutions/Services offered 292

14.2.7.3  Recent developments           293

14.2.8      DOLBEY SYSTEMS           295

14.2.8.1  Business overview 295

14.2.8.2  Products/Solutions/Services offered 295

14.2.8.3  Recent developments           296

14.2.9      AVERBIS               298

14.2.9.1  Business overview 298

14.2.9.2  Products/Solutions/Services offered 298

14.2.9.3  Recent developments           299

14.2.10   SAS INSTITUTE 300

14.2.10.1                 Business overview 300

14.2.10.2                 Products/Solutions/Services offered 300

14.2.10.3                 Recent developments           301

14.2.11   SOLVENTUM     304

14.2.11.1                 Business overview 304

14.2.11.2                 Products/Solutions/Services offered 305

14.2.11.3                 Recent developments           306

14.2.12   PRESS GANEY    307

14.2.13   ELLIPSIS HEALTH             307

14.2.14   LEXALYTICS       308

14.2.15   NVIDIA 309

14.2.16   GE HEALTHCARE             310

14.2.17   CLINITHINK       310

14.2.18   HPE        311

14.2.19   ONCORA MEDICAL         312

14.2.20   FLATIRON HEALTH         313

14.2.21   DATAVANT         314

14.2.22   EDIFECS               315

14.2.23   JOHN SNOW LABS            316

14.2.24   ITREX GROUP    316

14.2.25   KMS HEALTHCARE          317

14.2.26   APPINVENTIV   318

14.2.27   REVEAL HEALTHTECH  319

14.2.28   VERITIS                320

14.2.29   OPTUM 320

14.2.30   HEALTH CATALYST        321

14.2.31   AMBOSS               322

14.2.32   MARUTI TECHLABS        322

14.2.33   DEEPSCRIBE      323

14.3         OTHER PLAYERS              324

14.3.1      FORESEE MEDICAL         324

14.3.2      GNANI.AI             325

14.3.3      NOTABLE HEALTH          326

14.3.4      BIOFOURMIS     326

14.3.5      SUKI AI 327

14.3.6      WAVE HEALTH TECHNOLOGIES               328

14.3.7      CORTI   329

14.3.8      CLOUDMEDX    329

14.3.9      EMTELLIGENT  330

14.3.10   ENLITIC                331

14.3.11   DEEP 6 AI             332

15            ADJACENT AND RELATED MARKETS      333

15.1         INTRODUCTION              333

15.2         ARTIFICIAL INTELLIGENCE (AI) MARKET  – GLOBAL FORECAST TO 2030          333

15.2.1      MARKET DEFINITION   333

15.2.2      MARKET OVERVIEW       333

15.2.2.1  Artificial intelligence market, by offering         333

15.2.2.2  Artificial intelligence market, by technology    334

15.2.2.3  Artificial intelligence market, by business function        335

15.2.2.4  Artificial intelligence market, by vertical          336

15.2.2.5  Artificial intelligence market, by region            338

15.3         NATURAL LANGUAGE UNDERSTANDING MARKET  – GLOBAL FORECAST TO 2029       339

15.3.1      MARKET DEFINITION   339

15.3.2      MARKET OVERVIEW       339

15.3.2.1  Natural Language Understanding market, by offering   339

15.3.2.2  Natural Language Understanding market, by type         340

15.3.2.3  Natural Language Understanding market, by application                 340

15.3.2.4  Natural Language Understanding Market, by Vertical  342

15.3.2.5  Natural Language Understanding Market, by region     343

16            APPENDIX           344

16.1         DISCUSSION GUIDE        344

16.2         KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL                350

16.3         AVAILABLE CUSTOMIZATIONS 352

16.4         RELATED REPORTS         352

16.5         AUTHOR DETAILS           353

LIST OF TABLES

TABLE 1                UNITED STATES DOLLAR EXCHANGE RATE, 2020–2024              41

TABLE 2                FACTOR ANALYSIS          52

TABLE 3                GLOBAL NLP IN HEALTHCARE & LIFE SCIENCES MARKET SIZE AND GROWTH RATE,  2020–2024 (USD MILLION, Y-O-Y %)               57

TABLE 4                GLOBAL NLP IN HEALTHCARE & LIFE SCIENCES MARKET SIZE AND GROWTH RATE,  2025–2030 (USD MILLION, Y-O-Y %)               57

TABLE 5                US ADJUSTED RECIPROCAL TARIFF RATES                 70

TABLE 6                NLP IN HEALTHCARE & LIFE SCIENCES MARKET: ROLE OF PLAYERS IN ECOSYSTEM       79

TABLE 7                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             91

TABLE 8                EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 92

TABLE 9                ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 94

TABLE 10              MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             94

TABLE 11             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 95

TABLE 12              PATENTS FILED, 2016–2025           98

TABLE 13              LIST OF TOP PATENTS IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

2024–2025              99

TABLE 14              AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING, 2025                 102

TABLE 15              AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY APPLICATION, 2025               103

TABLE 16              NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025–2026              104

TABLE 17              PORTERS’ FIVE FORCES’ IMPACT ON NLP IN HEALTHCARE & LIFE SCIENCES MARKET              106

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS           108

TABLE 19              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 109

TABLE 20              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            113

TABLE 21              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            113

TABLE 22              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,

2020–2024 (USD MILLION)            114

TABLE 23              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,

2025–2030 (USD MILLION)            114

TABLE 24              STANDALONE NLP SOFTWARE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       114

TABLE 25              STANDALONE NLP SOFTWARE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       115

TABLE 26              INTEGRATED NLP SOFTWARE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   115

TABLE 27              INTEGRATED NLP SOFTWARE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   116

TABLE 28              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,

2020–2024 (USD MILLION)            117

TABLE 29              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,

2025–2030 (USD MILLION)            117

TABLE 30              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES,  2020–2024 (USD MILLION)                 118

TABLE 31              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES,  2025–2030 (USD MILLION)                 118

TABLE 32              TRAINING & CONSULTING SERVICES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       119

TABLE 33              TRAINING & CONSULTING SERVICES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       119

TABLE 34              SYSTEM INTEGRATION & IMPLEMENTATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)            120

TABLE 35              SYSTEM INTEGRATION & IMPLEMENTATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)            120

TABLE 36              SUPPORT & MAINTENANCE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   121

TABLE 37              SUPPORT & MAINTENANCE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   121

TABLE 38              MANAGED SERVICES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)                 122

TABLE 39              MANAGED SERVICES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)                 122

TABLE 40              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE,

2020–2024 (USD MILLION)            125

TABLE 41              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE,

2025–2030 (USD MILLION)            125

TABLE 42              CLOUD: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,

2020–2024 (USD MILLION)            125

TABLE 43              CLOUD: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,

2025–2030 (USD MILLION)            126

TABLE 44              ON-PREMISES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,  2020–2024 (USD MILLION)                 126

TABLE 45              ON-PREMISES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,  2025–2030 (USD MILLION)                 127

TABLE 46              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,

2020–2024 (USD MILLION)            130

TABLE 47              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,

2025–2030 (USD MILLION)            130

TABLE 48              NATURAL LANGUAGE UNDERSTANDING: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)       131

TABLE 49              NATURAL LANGUAGE UNDERSTANDING: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)       131

TABLE 50              NATURAL LANGUAGE GENERATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       132

TABLE 51              NATURAL LANGUAGE GENERATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       132

TABLE 52              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE,

2020–2024 (USD MILLION)          135

TABLE 53              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE,

2025–2030 (USD MILLION)            135

TABLE 54              OPTICAL CHARACTER RECOGNITION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       136

TABLE 55              OPTICAL CHARACTER RECOGNITION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       136

TABLE 56              NAMED ENTITY RECOGNITION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       137

TABLE 57              NAMED ENTITY RECOGNITION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   137

TABLE 58              SENTIMENT ANALYSIS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   138

TABLE 59              SENTIMENT ANALYSIS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   138

TABLE 60              TEXT CLASSIFICATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   139

TABLE 61              TEXT CLASSIFICATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   139

TABLE 62              TOPIC MODELING: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)                 140

TABLE 63              TOPIC MODELING: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,  2025–2030 (USD MILLION)                 140

TABLE 64              TEXT SUMMARIZATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   141

TABLE 65              TEXT SUMMARIZATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   141

TABLE 66              OTHER NLP TECHNIQUES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   142

TABLE 67              OTHER NLP TECHNIQUES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   142

TABLE 68              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,

2020–2024 (USD MILLION)            145

TABLE 69              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,

2025–2030 (USD MILLION)            146

TABLE 70              PATIENT CARE & ENGAGEMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       147

TABLE 71              PATIENT CARE & ENGAGEMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       147

TABLE 72              CLINICAL OPERATIONS & DECISION SUPPORT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)            149

TABLE 73              CLINICAL OPERATIONS & DECISION SUPPORT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)            150

TABLE 74              BIOMEDICAL RESEARCH & DRUG DEVELOPMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)                152

TABLE 75              BIOMEDICAL RESEARCH & DRUG DEVELOPMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)                152

TABLE 76              ADMINISTRATIVE & OPERATIONS MANAGEMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)   154

TABLE 77              ADMINISTRATIVE & OPERATIONS MANAGEMENT: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)   155

TABLE 78              GENOMICS & PRECISION MEDICINE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       157

TABLE 79              GENOMICS & PRECISION MEDICINE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       157

TABLE 80              MEDICAL EDUCATION & KNOWLEDGE DISSEMINATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)                159

TABLE 81              MEDICAL EDUCATION & KNOWLEDGE DISSEMINATION: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)                159

TABLE 82              OTHER APPLICATIONS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   160

TABLE 83              OTHER APPLICATIONS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   161

TABLE 84              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,

2020–2024 (USD MILLION)            164

TABLE 85              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,

2025–2030 (USD MILLION)            164

TABLE 86              CLINICAL PRACTITIONERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   165

TABLE 87              CLINICAL PRACTITIONERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   165

TABLE 88              HEALTHCARE RESEARCHERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2020–2024 (USD MILLION)   167

TABLE 89              HEALTHCARE RESEARCHERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY REGION, 2025–2030 (USD MILLION)   167

TABLE 90              HEALTHCARE ADMINISTRATORS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2020–2024 (USD MILLION)       169

TABLE 91              HEALTHCARE ADMINISTRATORS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY REGION, 2025–2030 (USD MILLION)       169

TABLE 92              HEALTH INSURANCE & PAYER PROFESSIONALS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)            171

TABLE 93              HEALTH INSURANCE & PAYER PROFESSIONALS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)            171

TABLE 94              PHARMACEUTICAL & BIOTECH COMPANIES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2020–2024 (USD MILLION)            172

TABLE 95              PHARMACEUTICAL & BIOTECH COMPANIES: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION, 2025–2030 (USD MILLION)            173

TABLE 96              OTHER END USERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,  2020–2024 (USD MILLION)            174

TABLE 97              OTHER END USERS: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,  2025–2030 (USD MILLION)            175

TABLE 98              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,

2020–2024 (USD MILLION)            178

TABLE 99              NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY REGION,

2025–2030 (USD MILLION)            178

TABLE 100            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 181

TABLE 101            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 181

TABLE 102            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2020–2024 (USD MILLION)                 181

TABLE 103            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2025–2030 (USD MILLION)                 181

TABLE 104            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2020–2024 USD MILLION)                 182

TABLE 105            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2025–2030 (USD MILLION)                 182

TABLE 106            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2020–2024 (USD MILLION)                 182

TABLE 107            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2025–2030 (USD MILLION)                 182

TABLE 108            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY DEPLOYMENT MODE, 2020–2024 (USD MILLION)        183

TABLE 109            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY DEPLOYMENT MODE, 2025–2030 (USD MILLION)        183

TABLE 110            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2020–2024 (USD MILLION)                 183

TABLE 111            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2025–2030 (USD MILLION)                 183

TABLE 112            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2020–2024 (USD MILLION)            184

TABLE 113            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2025–2030 (USD MILLION)            184

TABLE 114            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY APPLICATION, 2020–2024 (USD MILLION)       184

TABLE 115            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY APPLICATION, 2025–2030 (USD MILLION)       185

TABLE 116            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2020–2024 (USD MILLION)                 185

TABLE 117            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2025–2030 (USD MILLION)                 185

TABLE 118            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2020–2024 (USD MILLION)                 186

TABLE 119            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2025–2030 (USD MILLION)                 186

TABLE 120            US: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            187

TABLE 121            US: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            187

TABLE 122            CANADA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            188

TABLE 123            CANADA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            188

TABLE 124            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)          190

TABLE 125            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            190

TABLE 126            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,

2020–2024 (USD MILLION)            190

TABLE 127            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,

2025–2030 (USD MILLION)            190

TABLE 128            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,

2020–2024 USD MILLION)              191

TABLE 129            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,

2025–2030 (USD MILLION)            191

TABLE 130            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES, 2020–2024 (USD MILLION)            191

TABLE 131            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES, 2025–2030 (USD MILLION)            191

TABLE 132            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE,  2020–2024 (USD MILLION)                 192

TABLE 133            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE,  2025–2030 (USD MILLION)                 192

TABLE 134            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,

2020–2024 (USD MILLION)            192

TABLE 135            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,

2025–2030 (USD MILLION)          192

TABLE 136            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE,  2020–2024 (USD MILLION)                 193

TABLE 137            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE,  2025–2030 (USD MILLION)                 193

TABLE 138            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,  2020–2024 (USD MILLION)                 193

TABLE 139            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,  2025–2030 (USD MILLION)                 194

TABLE 140            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,

2020–2024 (USD MILLION)            194

TABLE 141            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,

2025–2030 (USD MILLION)            194

TABLE 142            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,

2020–2024 (USD MILLION)            195

TABLE 143            EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,

2025–2030 (USD MILLION)          195

TABLE 144            UK: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            196

TABLE 145            UK: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            196

TABLE 146            GERMANY: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            197

TABLE 147            GERMANY: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)        197

TABLE 148            FRANCE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            197

TABLE 149            FRANCE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)          198

TABLE 150            ITALY: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            198

TABLE 151            ITALY: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            198

TABLE 152            SPAIN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            199

TABLE 153            SPAIN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            199

TABLE 154            REST OF EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 200

TABLE 155            REST OF EUROPE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 200

TABLE 156            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 203

TABLE 157            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 203

TABLE 158            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2020–2024 (USD MILLION)                 203

TABLE 159            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2025–2030 (USD MILLION)                 203

TABLE 160            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2020–2024 USD MILLION)                 203

TABLE 161            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2025–2030 (USD MILLION)                 204

TABLE 162            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES, 2020–2024 (USD MILLION) 204

TABLE 163            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY PROFESSIONAL SERVICES, 2025–2030 (USD MILLION) 204

TABLE 164            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE, 2020–2024 (USD MILLION)            204

TABLE 165            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE, 2025–2030 (USD MILLION)            205

TABLE 166            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2020–2024 (USD MILLION)                 205

TABLE 167            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2025–2030 (USD MILLION)                 205

TABLE 168            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2020–2024 (USD MILLION)            205

TABLE 169            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2025–2030 (USD MILLION)            206

TABLE 170            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,  2020–2024 (USD MILLION)            206

TABLE 171            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION,  2025–2030 (USD MILLION)            206

TABLE 172            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2020–2024 (USD MILLION)                 207

TABLE 173            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2025–2030 (USD MILLION)                 207

TABLE 174            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2020–2024 (USD MILLION)                 207

TABLE 175            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2025–2030 (USD MILLION)                 208

TABLE 176            CHINA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            208

TABLE 177            CHINA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)          209

TABLE 178            JAPAN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            209

TABLE 179            JAPAN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)          210

TABLE 180            INDIA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            210

TABLE 181            INDIA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            210

TABLE 182            SOUTH KOREA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 211

TABLE 183            SOUTH KOREA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 211

TABLE 184            AUSTRALIA & NEW ZEALAND: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2020–2024 (USD MILLION)               212

TABLE 185            AUSTRALIA & NEW ZEALAND: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2025–2030 (USD MILLION)               212

TABLE 186            ASEAN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            213

TABLE 187            ASEAN: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)          213

TABLE 188            REST OF ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2020–2024 (USD MILLION)               214

TABLE 189            REST OF ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2025–2030 (USD MILLION)               214

TABLE 190            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2020–2024 (USD MILLION)               216

TABLE 191            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2025–2030 (USD MILLION)               216

TABLE 192            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY SOFTWARE, 2020–2024 (USD MILLION)             216

TABLE 193            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY SOFTWARE, 2025–2030 (USD MILLION)             216

TABLE 194            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY SERVICES, 2020–2024 USD MILLION)  217

TABLE 195            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY SERVICES, 2025–2030 (USD MILLION)                 217

TABLE 196            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2020–2024 (USD MILLION)                 217

TABLE 197            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2025–2030 (USD MILLION)                 217

TABLE 198            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY DEPLOYMENT MODE, 2020–2024 (USD MILLION)        218

TABLE 199            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY DEPLOYMENT MODE, 2025–2030 (USD MILLION)        218

TABLE 200            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE, 2020–2024 (USD MILLION)            218

TABLE 201            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE, 2025–2030 (USD MILLION)            218

TABLE 202            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2020–2024 (USD MILLION)            219

TABLE 203            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2025–2030 (USD MILLION)            219

TABLE 204            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY APPLICATION, 2020–2024 (USD MILLION)       219

TABLE 205            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY APPLICATION, 2025–2030 (USD MILLION)     220

TABLE 206            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER, 2020–2024 (USD MILLION)            220

TABLE 207            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER, 2025–2030 (USD MILLION)            220

TABLE 208            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY COUNTRY, 2020–2024 (USD MILLION)               221

TABLE 209            MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY COUNTRY, 2025–2030 (USD MILLION)               221

TABLE 210            SAUDI ARABIA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 222

TABLE 211            SAUDI ARABIA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 222

TABLE 212            UAE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            223

TABLE 213            UAE: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            223

TABLE 214            SOUTH AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 224

TABLE 215            SOUTH AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 224

TABLE 216            ISRAEL: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)          224

TABLE 217            ISRAEL: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            225

TABLE 218            REST OF MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY OFFERING, 2020–2024 (USD MILLION)       226

TABLE 219            REST OF MIDDLE EAST & AFRICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,  BY OFFERING, 2025–2030 (USD MILLION)       226

TABLE 220            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING, 2020–2024 (USD MILLION)                 227

TABLE 221            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 228

TABLE 222            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2020–2024 (USD MILLION)                 228

TABLE 223            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SOFTWARE,  2025–2030 (USD MILLION)                 228

TABLE 224            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2020–2024 USD MILLION)                 228

TABLE 225            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY SERVICES,  2025–2030 (USD MILLION)                 228

TABLE 226            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2020–2024 (USD MILLION)                 229

TABLE 227            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY PROFESSIONAL SERVICES, 2025–2030 (USD MILLION)                 229

TABLE 228            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE, 2020–2024 (USD MILLION)            229

TABLE 229            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY DEPLOYMENT MODE, 2025–2030 (USD MILLION)            229

TABLE 230            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2020–2024 (USD MILLION)                 230

TABLE 231            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TYPE,  2025–2030 (USD MILLION)                 230

TABLE 232            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2020–2024 (USD MILLION)            230

TABLE 233            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY NLP TECHNIQUE, 2025–2030 (USD MILLION)            231

TABLE 234            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION, 2020–2024 (USD MILLION)                 231

TABLE 235            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY APPLICATION, 2025–2030 (USD MILLION)                 232

TABLE 236            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2020–2024 (USD MILLION)                 232

TABLE 237            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY END USER,  2025–2030 (USD MILLION)                 232

TABLE 238            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2020–2024 (USD MILLION)                 233

TABLE 239            LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY COUNTRY,  2025–2030 (USD MILLION)                 233

TABLE 240            BRAZIL: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            234

TABLE 241            BRAZIL: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            234

TABLE 242            MEXICO: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2020–2024 (USD MILLION)            234

TABLE 243            MEXICO: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,

2025–2030 (USD MILLION)            235

TABLE 244            ARGENTINA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2020–2024 (USD MILLION)                 235

TABLE 245            ARGENTINA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET, BY OFFERING,  2025–2030 (USD MILLION)                 236

TABLE 246            REST OF LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2020–2024 (USD MILLION)               236

TABLE 247            REST OF LATIN AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET,

BY OFFERING, 2025–2030 (USD MILLION)               237

TABLE 248            OVERVIEW OF STRATEGIES ADOPTED BY KEY NLP IN HEALTHCARE & LIFE SCIENCES VENDORS, 2022–2025                 238

TABLE 249            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DEGREE OF COMPETITION    242

TABLE 250            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: REGIONAL FOOTPRINT            251

TABLE 251            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: OFFERING FOOTPRINT             252

TABLE 252            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: APPLICATION FOOTPRINT     253

TABLE 253            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: END USER FOOTPRINT              254

TABLE 254            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: KEY STARTUPS/SMES, 2024      257

TABLE 255            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              258

TABLE 256            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY  2022–MAY 2025            259

TABLE 257            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DEALS,

JANUARY 2022–MAY 2025               260

TABLE 258            IBM: BUSINESS OVERVIEW           263

TABLE 259            IBM: PRODUCTS/SOLUTIONS/SERVICES OFFERED             264

TABLE 260            IBM: PRODUCT LAUNCHES & ENHANCEMENTS                 265

TABLE 261            IBM: DEALS        265

TABLE 262            MICROSOFT: BUSINESS OVERVIEW         267

TABLE 263            MICROSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED    268

TABLE 264            MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS             269

TABLE 265            MICROSOFT: DEALS       270

TABLE 266            GOOGLE: BUSINESS OVERVIEW 273

TABLE 267            GOOGLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED             274

TABLE 268            GOOGLE: PRODUCT LAUNCHES & ENHANCEMENTS             275

TABLE 269            GOOGLE: DEALS              275

TABLE 270            AWS: BUSINESS OVERVIEW          278

TABLE 271            AWS: PRODUCTS/SOLUTIONS/SERVICES OFFERED             279

TABLE 272            AWS: PRODUCT LAUNCHES & ENHANCEMENTS                 279

TABLE 273            AWS: DEALS       280

TABLE 274            AWS: OTHERS    282

TABLE 275            IQVIA: BUSINESS OVERVIEW       283

TABLE 276            IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED             284

TABLE 277            IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS             285

TABLE 278            IQVIA: DEALS    286

TABLE 279            IQVIA: OTHERS 287

TABLE 280            ORACLE: BUSINESS OVERVIEW 288

TABLE 281            ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED             289

TABLE 282            ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS             290

TABLE 283            ORACLE: DEALS                290

TABLE 284            INOVALON: BUSINESS OVERVIEW            292

TABLE 285            INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED             292

TABLE 286            INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS             293

TABLE 287            INOVALON: DEALS          293

TABLE 288            INOVALON: OTHERS      294

TABLE 289            DOLBEY SYSTEMS: BUSINESS OVERVIEW                 295

TABLE 290            DOLBEY SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED    295

TABLE 291            DOLBEY SYSTEMS: PRODUCT LAUNCHES & ENHANCEMENTS             296

TABLE 292            DOLBEY SYSTEMS: DEALS            296

TABLE 293            AVERBIS: BUSINESS OVERVIEW 298

TABLE 294            AVERBIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED             298

TABLE 295            AVERBIS: PRODUCT LAUNCHES & ENHANCEMENTS             299

TABLE 296            AVERBIS: DEALS               299

TABLE 297            SAS INSTITUTE: BUSINESS OVERVIEW   300

TABLE 298            SAS INSTITUTE: PRODUCTS/SOLUTIONS/SERVICES OFFERED    300

TABLE 299            SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS             301

TABLE 300            SAS INSTITUTE: DEALS 301

TABLE 301            SAS INSTITUTE: OTHERS              303

TABLE 302            SOLVENTUM: BUSINESS OVERVIEW        304

TABLE 303            SOLVENTUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED    305

TABLE 304            SOLVENTUM: DEALS      306

TABLE 305            SOLVENTUM: OTHERS  306

TABLE 306            ARTIFICIAL INTELLIGENCE MARKET, BY OFFERING, 2019–2023 (USD MILLION)     334

TABLE 307            ARTIFICIAL INTELLIGENCE MARKET, BY OFFERING, 2024–2030 (USD BILLION)      334

TABLE 308            ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY, 2019–2023 (USD BILLION)             335

TABLE 309            ARTIFICIAL INTELLIGENCE MARKET, BY TECHNOLOGY, 2024–2030 (USD BILLION)             335

TABLE 310            ARTIFICIAL INTELLIGENCE MARKET, BY BUSINESS FUNCTION,

2019–2023 (USD BILLION)             336

TABLE 311            ARTIFICIAL INTELLIGENCE MARKET, BY BUSINESS FUNCTION,

2024–2030 (USD BILLION)             336

TABLE 312            ARTIFICIAL INTELLIGENCE MARKET, BY VERTICAL, 2019–2023 (USD BILLION)      337

TABLE 313            ARTIFICIAL INTELLIGENCE MARKET, BY VERTICAL, 2024–2030 (USD BILLION)      337

TABLE 314            ARTIFICIAL INTELLIGENCE MARKET, BY REGION, 2019–2023 (USD BILLION)           338

TABLE 315            ARTIFICIAL INTELLIGENCE MARKET, BY REGION, 2024–2030 (USD BILLION)           338

TABLE 316            NATURAL LANGUAGE UNDERSTANDING MARKET, BY SOLUTION,

2019–2023 (USD MILLION)            339

TABLE 317            NATURAL LANGUAGE UNDERSTANDING MARKET, BY SOLUTION,

2024–2029 (USD MILLION)            340

TABLE 318            NATURAL LANGUAGE UNDERSTANDING MARKET, BY TYPE,

2019–2023 (USD MILLION)            340

TABLE 319            NATURAL LANGUAGE UNDERSTANDING MARKET, BY TYPE,

2024–2029 (USD MILLION)            340

TABLE 320            NATURAL LANGUAGE UNDERSTANDING MARKET, BY APPLICATION,

2019–2023 (USD MILLION)            341

TABLE 321            NATURAL LANGUAGE UNDERSTANDING MARKET, BY APPLICATION,

2024–2029 (USD MILLION)            341

TABLE 322            NATURAL LANGUAGE UNDERSTANDING MARKET, BY VERTICAL,

2019–2023 (USD MILLION)            342

TABLE 323            NATURAL LANGUAGE UNDERSTANDING MARKET, BY VERTICAL,

2024–2029 (USD MILLION)            343

TABLE 324            NATURAL LANGUAGE UNDERSTANDING MARKET, BY REGION,

2019–2023 (USD MILLION)            343

TABLE 325            NATURAL LANGUAGE UNDERSTANDING MARKET, BY REGION,

2024–2029 (USD MILLION)            343

LIST OF FIGURES

FIGURE 1              NLP IN HEALTHCARE & LIFE SCIENCES MARKET: RESEARCH DESIGN     43

FIGURE 2              NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DATA TRIANGULATION            47

FIGURE 3              NLP IN HEALTHCARE & LIFE SCIENCES MARKET: TOP-DOWN AND BOTTOM-UP APPROACHES 48

FIGURE 4              MARKET SIZE ESTIMATION METHODOLOGY—APPROACH 1, BOTTOM-UP (SUPPLY-SIDE): REVENUE FROM AVATAR TYPES IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET               49

FIGURE 5              MARKET SIZE ESTIMATION METHODOLOGY—APPROACH 2, BOTTOM-UP  (SUPPLY-SIDE): COLLECTIVE REVENUE FROM KEY COMPANIES IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET                49

FIGURE 6              MARKET SIZE ESTIMATION METHODOLOGY—APPROACH 3, BOTTOM-UP  (SUPPLY-SIDE): COLLECTIVE REVENUE FROM BUSINESS UNITS (BU) OF  KEY VENDORS IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET               50

FIGURE 7              MARKET SIZE ESTIMATION METHODOLOGY—APPROACH 4, BOTTOM-UP (DEMAND-SIDE): SHARE OF NLP IN HEALTHCARE & LIFE SCIENCES THROUGH OVERALL IT SPENDING ON SUSTAINABLE SOLUTIONS           51

FIGURE 8              SOFTWARE SEGMENT ESTIMATED TO HOLD LARGER MARKET SHARE IN 2025               57

FIGURE 9              NAMED ENTITY RECOGNITION SEGMENT SET TO REGISTER LARGEST MARKET SHARE IN 2025                58

FIGURE 10            CLINICAL OPERATIONS & DECISION SUPPORT SEGMENT TO HOLD LARGEST MARKET SHARE IN 2025  58

FIGURE 11            PHARMACEUTICAL & BIOTECH COMPANIES TO LEAD MARKET IN 2025   59

FIGURE 12            ASIA PACIFIC TO REGISTER HIGHEST CAGR BETWEEN 2025 AND 2030               60

FIGURE 13            RISING DEMAND FOR IMPROVED CLINICAL DECISION-MAKING AND ACCELERATED DRUG DISCOVERY AND CLINICAL TRIALS TO DRIVE MARKET          61

FIGURE 14            GENOMICS & PRECISION MEDICINE SEGMENT TO ACCOUNT FOR HIGHEST GROWTH RATE DURING FORECAST PERIOD         61

FIGURE 15            NAMED ENTITY RECOGNITION AND HEALTHCARE RESEARCHERS TO LEAD MARKET IN 2025                 62

FIGURE 16            NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2025   62

FIGURE 17            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    64

FIGURE 18            NLP IN HEALTHCARE & LIFE SCIENCES MARKET EVOLUTION       76

FIGURE 19            FUNCTIONAL ELEMENTS OF NLP IN HEALTHCARE & LIFE SCIENCES SOLUTIONS       77

FIGURE 20            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: SUPPLY CHAIN ANALYSIS         78

FIGURE 21            KEY PLAYERS IN NLP IN HEALTHCARE & LIFE SCIENCES ECOSYSTEM 81

FIGURE 22            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: INVESTMENT LANDSCAPE AND FUNDING SCENARIO                 83

FIGURE 23            NUMBER OF PATENTS GRANTED IN LAST 10 YEARS, 2016–2025               98

FIGURE 24            REGIONAL ANALYSIS OF PATENTS GRANTED, 2016–2025              101

FIGURE 25            AVERAGE SELLING PRICE, BY APPLICATION, 2025        103

FIGURE 26            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: PORTER’S FIVE FORCES ANALYSIS       106

FIGURE 27            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS           108

FIGURE 28            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 109

FIGURE 29            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS/CLIENTS            110

FIGURE 30            SERVICES SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD          112

FIGURE 31            INTEGRATED NLP SOFTWARE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 113

FIGURE 32            MANAGED SERVICES SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD      116

FIGURE 33            TRAINING & CONSULTING SERVICES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD                 118

FIGURE 34            CLOUD SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD          124

FIGURE 35            NLG SEGMENT TO REGISTER HIGHER CAGR DURING FORECAST PERIOD       129

FIGURE 36            TEXT SUMMARIZATION SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD      134

FIGURE 37            GENOMICS & PRECISION MEDICINE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD                 145

FIGURE 38            PHARMACEUTICAL & BIOTECH COMPANIES SEGMENT TO REGISTER HIGHER CAGR DURING FORECAST PERIOD                163

FIGURE 39            NORTH AMERICA TO BE LARGEST REGIONAL MARKET DURING FORECAST PERIOD    177

FIGURE 40            INDIA TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD         178

FIGURE 41            NORTH AMERICA: NLP IN HEALTHCARE & LIFE SCIENCES MARKET SNAPSHOT 180

FIGURE 42            ASIA PACIFIC: NLP IN HEALTHCARE & LIFE SCIENCES MARKET SNAPSHOT 202

FIGURE 43            REVENUE ANALYSIS OF KEY PLAYERS IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET, 2020–2024         241

FIGURE 44            SHARE OF LEADING COMPANIES IN NLP IN HEALTHCARE & LIFE SCIENCES MARKET, 2024   242

FIGURE 45            PRODUCT COMPARATIVE ANALYSIS (OFFERING)       244

FIGURE 46            PRODUCT COMPARATIVE ANALYSIS (APPLICATION)                246

FIGURE 47            FINANCIAL METRICS OF KEY VENDORS 248

FIGURE 48            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS   248

FIGURE 49            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 250

FIGURE 50            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: COMPANY FOOTPRINT             251

FIGURE 51            NLP IN HEALTHCARE & LIFE SCIENCES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        256

FIGURE 52            IBM: COMPANY SNAPSHOT         264

FIGURE 53            MICROSOFT: COMPANY SNAPSHOT        268

FIGURE 54            GOOGLE: COMPANY SNAPSHOT               274

FIGURE 55            AWS: COMPANY SNAPSHOT        278

FIGURE 56            IQVIA: COMPANY SNAPSHOT     284

FIGURE 57            ORACLE: COMPANY SNAPSHOT                289

FIGURE 58            SOLVENTUM: COMPANY SNAPSHOT      305

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧